EC 2.4.1.231 [alpha,alpha-trehalose phosphorylase (configuration-retaining)] inhibitor

Term ID

CHEBI:83757

Synonyms

alpha,alpha-trehalose phosphorylase (configuration-retaining) (EC 2.4.1.231) inhibitor
alpha,alpha-trehalose phosphorylase (configuration-retaining) (EC 2.4.1.231) inhibitors
alpha,alpha-trehalose phosphorylase (configuration-retaining) inhibitor
alpha,alpha-trehalose phosphorylase (configuration-retaining) inhibitors
alpha,alpha-trehalose:phosphate alpha-D-glucosyltransferase inhibitor
alpha,alpha-trehalose:phosphate alpha-D-glucosyltransferase inhibitors
EC 2.4.1.231 [alpha,alpha-trehalose phosphorylase (configuration-retaining)] inhibitors
EC 2.4.1.231 inhibitor
EC 2.4.1.231 inhibitors
trehalose phosphorylase inhibitor
trehalose phosphorylase inhibitors

Definition

An EC 2.4.1.* (hexosyltransferase) inhibitor that interferes with the action of alpha,alpha-trehalose phosphorylase (configuration-retaining) (EC 2.4.1.231).

References

Wikipedia:Alpha,alpha-trehalose_phosphorylase_(configuration-retaining)

Ontology

ChEBI ( EBI )

Relationships

is a type of: EC 2.4.1.* (hexosyltransferase) inhibitor

EC 2.4.1.* (hexosyltransferase) inhibitor Show first 5 Terms
inverse has_role: validamycin A validamycin A(1+)

validamycin A validamycin A(1+) Show first 5 Terms

Phenotype

Phenotype resulting from EC 2.4.1.231 [alpha,alpha-trehalose phosphorylase (configuration-retaining)] inhibitor

Phenotype where environments contain EC 2.4.1.231 [alpha,alpha-trehalose phosphorylase (configuration-retaining)] inhibitor

Phenotype modified by environments containing EC 2.4.1.231 [alpha,alpha-trehalose phosphorylase (configuration-retaining)] inhibitor

Human Disease Model